Immunoglobulin D myeloma - Problems with diagnosing and staging (own experience and literature review)

Leukemia and Lymphoma

Volumn 46, Issue 7, 2005, Pages 1029-1037

  Kuliszkiewicz Janus, Małgorzata ^a   Zimny, Anna ^a   Sokolska, Violetta ^a   Saşiadek, Marek ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Diagnostic problems; IgD myeloma; Prognosis; Staging

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; AMYLOIDOSIS; AUTOIMMUNE DISEASE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ELECTROPHORESIS; FEMALE; FREQUENCY ANALYSIS; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; JAPAN; KIDNEY DISEASE; LABORATORY TEST; MALE; MULTIPLE MYELOMA; NEUROLOGIC DISEASE; PLASMACYTOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL TIME; SYMPTOMATOLOGY;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN D; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 22144498894     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/00268970500096442     Document Type: Review

References (12)

1. Foerester J, Paraskevas F. Multiple myeloma. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rogers GM, editors, Wintrobe's clinical hematology. Baltimore: Williams & Wilkins; 1999. p 2631-2680.
2. Blade J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol/Oncol Clin North Am 1999;13:1259-1272.
3. Shimamoto Y, Anami Y, Yamaguchi M. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur J Haematol 1991;47:262-267.
4. Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W. IgD multiple myeloma. Review of 133 cases. Arch Intern Med 1975;135:87-93.
5. Blade J, Lust JA, Kyle RA. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994;12:2398-2404.
6. Sinclair D. IgD myeloma: clinical, biological and laboratory features. Clin Lab 2002;48:617-622.
7. Sinclair D, Cranfield T. IgD myeloma: a potential missed diagnosis. Ann Clin Biochem 2001;38:564-565.
8. Homan H, Ohtubo Y, Ito H et al. IgD multiple myeloma with renal involvement: case report. Japan J Med 1990;29:212-215.
9. Kyle RA. IgD multiple myeloma: a cure at 21 years. Am J Hematol 1998;29:41-43.
10. Takemori N, Kondo K, Kawamura T, Imai K, Sakurai H, Sato T. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment. Am J Hematol 2001;66:62-63.
11. Fukuno K, Tsurumi H, Yamada T, Oyama M, Moriwaki H. Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide. Rinsho Ketsueki 2000;41:513-518.
12. Wechalekar A, Amato D, Chen C, Stewart AK, Reece D. IgD multiple myeloma - a clinical profile and outcome with chemotherapy and autologous stem cell transplantation. Ann Hematol 2005;84:115-117.